EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Association Between Metformin Use and Risk of Lung Cancer in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

Mehdi Karimi iD, Farnaz Hooshmand iD, Kiana Mohammadian iD, Seyed Morteza Ali Pourfaraji iD, Masoud Mortezazadeh iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70651 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Reports, 2026. Verfasst von Mehdi Karimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine. Hauptthemen laut MEDLINE: Metformin, Lung Neoplasms, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Lung cancer remains one of the leading causes of cancer‐related mortality worldwide. Type 2 diabetes mellitus (T2DM), the most prevalent endocrine disorder, is commonly managed with Metformin, an antidiabetic medication that has demonstrated potential anticancer properties. This meta‐analysis aimed to discover the association between Metformin use and the risk of lung cancer in patients with T2DM.

Methods

A comprehensive search of online databases was conducted up to January 1, 2026, to identify relevant observational studies. After screening, appropriate data were extracted. Meta‐analyses utilized the most fully adjusted hazard ratio (HR) with corresponding 95% confidence intervals (CI) as the effect measures. All statistical analyses were performed using R Statistical Software.

Results

The pooled analysis of 29 observational studies showed a significant reduction in lung cancer risk among Metformin users compared with nonusers (HR: 0.85, 95% CI: [0.77–0.94], p = 0.002). Subgroup analyses revealed significant associations in cohort studies (HR: 0.79, 95% CI: [0.70–0.89], p < 0.01) and in studies conducted in Asia (HR: 0.82, 95% CI: [0.68–0.99], p = 0.04). Extended Metformin use (> 3 years) was associated with a significant reduction in lung cancer risk (HR: 0.87, 95% CI: [0.79–0.95]; p < 0.01), whereas no significant effect was observed for shorter durations.

Conclusion

This meta‐analysis indicated a potential protective effect of Metformin use in individuals with T2DM against lung cancer, with a significant risk reduction observed, particularly among long‐term users and in Asian populations. The significant associations identified in cohort studies and in extended‐duration use underscore metformin's promise in lung cancer prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminLung NeoplasmsDiabetes Mellitus, Type 2Hypoglycemic AgentsHumansRisk FactorsObservational Studies as TopicRisk Assessment

Stichwörter der Autor:innen

diabetesepidemiologylung Cancermeta‐analysismetforminrisk

Substanzen

MetforminHypoglycemic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine.
  • Department of Hematology-Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  • Division of Hematology and Blood Banking, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mehdi Karimi, Farnaz Hooshmand, Kiana Mohammadian, Seyed Morteza Ali Pourfaraji, Masoud Mortezazadeh

Zitieren

APA

Karimi, M., Hooshmand, F., Mohammadian, K., Pourfaraji, S. M. A., & Mortezazadeh, M. (2026). Association Between Metformin Use and Risk of Lung Cancer in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.70651

Vancouver

Karimi M, Hooshmand F, Mohammadian K, Pourfaraji SMA, Mortezazadeh M. Association Between Metformin Use and Risk of Lung Cancer in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis. Cancer Reports. 2026. doi:10.1002/cnr2.70651

BibTeX
@article{Karimi2026,
  author = {Karimi, Mehdi and Hooshmand, Farnaz and Mohammadian, Kiana and Pourfaraji, Seyed Morteza Ali and Mortezazadeh, Masoud},
  title = {Association Between Metformin Use and Risk of Lung Cancer in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70651}
}
Kostenlos starten →